{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:43:27Z","timestamp":1776923007072,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["QKHJC-ZK[2024"],"award-info":[{"award-number":["QKHJC-ZK[2024"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["QKHZDZXZ[2024]015"],"award-info":[{"award-number":["QKHZDZXZ[2024]015"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360112"],"award-info":[{"award-number":["32360112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22067003"],"award-info":[{"award-number":["22067003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117910","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:11:51Z","timestamp":1751022711000},"page":"117910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a novel Genipin derivative targeting YB-1 to enhance the P-glycoprotein-mediated paclitaxel sensitivity of paclitaxel-resistant non-small cell lung cancer"],"prefix":"10.1016","volume":"297","author":[{"given":"Lulu","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maofei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhen","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117910_bib1","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117910_bib2","first-page":"16","article-title":"World cancer report: cancer research for cancer prevention","author":"Wild","year":"2020","journal-title":"Lyon: Int. Agen. Res. Cancer"},{"key":"10.1016\/j.ejmech.2025.117910_bib3","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117910_bib4","first-page":"753","article-title":"Recent advances of research on risk factors of lung cancer","volume":"30","author":"Sun","year":"2022","journal-title":"Mod. Oncol."},{"key":"10.1016\/j.ejmech.2025.117910_bib5","first-page":"7","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117910_bib6","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117910_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117910_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.117910_bib9","first-page":"687","article-title":"Effectiveness of PD-(L) 1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (nsq-NSCLC) with PD-L1-high expression using real-world data","volume":"32","author":"P\u00e9rol","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2025.117910_bib10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/annonc\/mdq036","article-title":"A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease","volume":"21","author":"Zatloukal","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2025.117910_bib11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.ejca.2014.01.020","article-title":"The Tokyo cooperative oncology group, biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801\/BIRIP trial)","volume":"50","author":"Higuchi","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117910_bib12","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3390\/ijms22063199","article-title":"Pleiotropic roles of ABC transporters in breast cancer","volume":"22","author":"He","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117910_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/wrna.1200","article-title":"YB-1 protein: functions and regulation","volume":"5","author":"Lyabin","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.ejmech.2025.117910_bib14","doi-asserted-by":"crossref","first-page":"48110","DOI":"10.18632\/oncotarget.18262","article-title":"YB-1 regulates tumor growth by promoting MACC1\/c-Met pathway in human lung adenocarcinoma","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117910_bib15","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3748\/wjg.v27.i28.4667","article-title":"Y-box binding protein qaugments sorafenib resistance via the PI3K\/Akt signaling pathway in hepatocellular carcinoma","volume":"27","author":"Liu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2025.117910_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.117910_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nm0497-447","article-title":"Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression","volume":"3","author":"Bargou","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117910_bib18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00345-014-1469-0","article-title":"Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity","volume":"33","author":"Saupe","year":"2015","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejmech.2025.117910_bib19","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/0008-5472.CAN-15-2361","article-title":"Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway","volume":"76","author":"Mo","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117910_bib20","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/mp500066v","article-title":"Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?","volume":"11","author":"Panzarini","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.117910_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/13880209.2016.1241810","article-title":"Chrysosplenetin inhibits artemisinin efflux in P-gpover-expressing Caco-2 cells and reverses P-gp\/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine","volume":"55","author":"Ma","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2025.117910_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3892\/etm.2016.4011","article-title":"Geniposide reverses multidrug resistance In vitro an in vivo by inhibiting the efflux function and expression of P-glycoprotein","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2025.117910_bib23","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1021\/ja905302f","article-title":"Organocatalytic synthesis of spiro[pyrrolidin-3,3\u2032-oxindoles] with high enantiopurity and structural diversity","volume":"131","author":"Chen","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117910_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.117910_bib25","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117910_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cbi.2015.07.003","article-title":"BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxo-rubicin-resistant human myelogenous leukemia (K562\/DOX) cells via generation of reactive oxygen species","volume":"239","author":"Wang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.117910_bib27","doi-asserted-by":"crossref","first-page":"82139","DOI":"10.18632\/oncotarget.10080","article-title":"YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117910_bib28","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/s41598-017-02279-x","article-title":"Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer","volume":"7","author":"Heumann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117910_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/abbs\/gmw012","article-title":"YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients","volume":"48","author":"Zheng","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejmech.2025.117910_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bies.10300","article-title":"The pleiotropic functions of the Y-box-binding protein, YB-1","volume":"25","author":"Kohno","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2025.117910_bib31","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.18632\/oncotarget.3602","article-title":"Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances enzalutamide anti-tumor efficacy in castration resistant prostate cancer","volume":"6","author":"Shiota","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117910_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/DDDT.S185514","article-title":"YB-1 modulates the drug resistance of glioma cells by activation of MDM2\/p53 pathway","volume":"13","author":"Tong","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117910_bib33","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Meier","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2025.117910_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0625.2012.01448.x","article-title":"MAPK and PI3K\/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop","volume":"21","author":"Sinnberg","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"28","key":"10.1016\/j.ejmech.2025.117910_bib35","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3748\/wjg.v27.i28.4667","article-title":"Y-box binding protein qaugments sorafenib resistance via the PI3K\/Akt signaling pathway in hepatocellular carcinoma","volume":"27","author":"Liu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2025.117910_bib36","doi-asserted-by":"crossref","first-page":"1255784","DOI":"10.1126\/science.1255784","article-title":"Tracking cancer drugs in living cells by thermal profiling of the proteome","volume":"346","author":"Savitski","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117910_bib37","doi-asserted-by":"crossref","first-page":"101552","DOI":"10.1016\/j.xcrm.2024.101552","article-title":"Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy","volume":"5","author":"Arpit","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejmech.2025.117910_bib38","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1158\/1538-7445.AM2024-5926","article-title":"YB-1 inhibition as an effective approach for the treatment of osteosarcoma","volume":"84","author":"Kirsten","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117910_bib39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cancers14041090","article-title":"The roles of microRNAs in cancer multidrug resistance","volume":"14","author":"Pavl\u00edkov\u00e1","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.117910_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1566524020666200226124336","article-title":"The roles of micro RNAs in multidrug-resistance mechanisms in gastric cancer","volume":"20","author":"Zeng","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117910_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjc.1991.152","article-title":"Multidrug resistance (mdr) genes in human cancer","volume":"63","author":"Nooter","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117910_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/028418698429964","article-title":"Physiologic and pathologic drug resistance in ovarian carcinoma-a hypothesis based on a clonal progression model","volume":"37","author":"Pusztai","year":"1998","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ejmech.2025.117910_bib43","first-page":"135","article-title":"Lemon-derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis-triggered energy dissipation and energy production reduction","volume":"58","author":"Xiao","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejmech.2025.117910_bib44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117910_bib45","doi-asserted-by":"crossref","first-page":"100682","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.117910_bib46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41401-023-01219-y","article-title":"Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117910_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.chembiol.2021.02.014","article-title":"Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer","volume":"28","author":"Dhanir","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117910_bib48","article-title":"Bufalin reverses ABCB1- mediated resistance to docetaxel in breast cancer","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.117910_bib49","doi-asserted-by":"crossref","first-page":"108865","DOI":"10.1016\/j.cbi.2019.108865","article-title":"Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer","volume":"315","author":"Attia","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.117910_bib50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41467-019-09312-9","article-title":"Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer","volume":"10","author":"Christie","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117910_bib51","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1039\/C8OB00677F","article-title":"Design and synthesis of novel monoterpenoid indole alkaloid-like analogues and their antitumour activities in vitro","volume":"16","author":"Fang","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117910_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2013.12.026","article-title":"WLIP derived from Lasiosphaera fenzlii Reich exhibits anti-tumor activity and induces cell cycle arrest through PPAR-g associated pathways","volume":"19","author":"Meng","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117910_bib53","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ncb0901-802","article-title":"Nuclear localization of EGF receptor and its potential new role as a transcription factor","volume":"3","author":"Lin","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117910_bib54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/onc.2012.90","article-title":"Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor","volume":"32","author":"Iida","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.117910_bib55","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1073\/pnas.1910862117","article-title":"Drosophila YBX1 homolog YPS promotes ovarian germ line stem cell development by preferentially recognizing 5-methylcytosine RNAs","volume":"117","author":"Zou","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117910_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20121323","article-title":"YB-1: Oncoprotein, prognostic marker and therapeutic target?","volume":"449","author":"Lasham","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117910_bib57","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/anie.201912489","article-title":"Synthesis and target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke","volume":"59","author":"Gao","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117910_bib58","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.117910_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-020-01256-9","article-title":"Characterization of a novel HDAC\/RXR\/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.117910_bib60","doi-asserted-by":"crossref","first-page":"111442","DOI":"10.1016\/j.msec.2020.111442","article-title":"Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel","volume":"119","author":"Wang","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejmech.2025.117910_bib61","first-page":"1","article-title":"BRM\/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2\/STAT3 signaling","volume":"28","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.117910_bib62","doi-asserted-by":"crossref","first-page":"113919","DOI":"10.1016\/j.ejmech.2021.113919","article-title":"Synthesis and biological evaluation of novel schisanhenol derivatives as potential hepatoprotective agents","volume":"227","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:00:47Z","timestamp":1776920447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":62,"alternative-id":["S0223523425006750"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117910","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel Genipin derivative targeting YB-1 to enhance the P-glycoprotein-mediated paclitaxel sensitivity of paclitaxel-resistant non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117910"}}